🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pemphigus vulgaris (PV) is a rare, chronic, debilitating, and potentially l...
Status
Unknown
Location
Tongji Hospital
Start Date
2021-02-01
Trial ID
NCT05303272
Treatments Being Tested
The purpose of this study is to compare subcutaneous Abatacept to placebo i...
Status
Completed
Location
Arizona Arthritis & Rheumatology Research PLLC
Start Date
2013-06-17
Trial ID
NCT01860976
The core and extension studies assessed the safety and efficacy of secukinu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-09
Trial ID
NCT01350804
The purpose of this study is to compare the clinical efficacy including joi...
Status
Completed
Location
Local Institution
Start Date
2013-04-11
Trial ID
NCT01758198
Treatments Being Tested
The purpose of this study is to evaluate (Abatacept) for treatment of lupus...
Status
Terminated
Location
University Of Alabama At Birmingham (Uab)
Start Date
2013-01-22
Trial ID
NCT01714817
Treatments Being Tested
Systemic sclerosis (scleroderma) is an autoimmune connective tissue disease...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2008-11
Trial ID
NCT00442611
Background: CTLA4 stands for cytotoxic T-lymphocyte antigen-4. It is a pro...
Status
Withdrawn
Location
National Institutes of Health Clinical Center
Start Date
2023-11-30
Trial ID
NCT03733067
The purpose of this study is to investigate whether the combination of abat...
Status
Withdrawn
Location
Division of Rheumatology, UCLA David Geffen School of Medicine
Start Date
2014-07
Trial ID
NCT02053727
The purpose of this study is to determine if abatacept is effective in the ...
Status
Completed
Location
Rheumatology Associates Of North Alabama, P.C.
Start Date
2015-09-03
Trial ID
NCT02504268
Treatments Being Tested
The primary purpose of the protocol is to demonstrate the ability of abatac...
Status
Completed
Location
Rheumatology Associates Of North Alabama, P.C.
Start Date
2010-12
Trial ID
NCT01142726
Treatments Being Tested